Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10-K
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
News
TYPE
HEADLINE
FILED AT
8-K
Genprex Announces Results from Translational Analysis of REQORSA at GSA 2026 Annual Scientific Meeting
8-K
Genprex to Present New Research on TROP2 as a Potential Predictive Biomarker for REQORSA at the 2026 EORTC-NCI-AACR Symposium
8-K
Genprex Announces Research from Meharry Medical College Collaboration to be Featured at Gerontological Society of America 2026 Annual Scientific Meeting
8-K
Peer-reviewed mouse study links TUSC2 loss to mitochondrial dysfunction, impaired protein homeostasis, and sex-specific hippocampal aging changes
8-K
Genprex Enters Manufacturing Agreement to Scale Diabetes Gene Therapy Program
8-K
Genprex, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement
Prospectus
TYPE
HEADLINE
FILED AT
Registrations
TYPE
HEADLINE
FILED AT
Proxies
TYPE
HEADLINE
FILED AT
DEF 14A
Form DEF 14A - Other definitive proxy statements
PRE 14A
Form PRE 14A - Other preliminary proxy statements
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
DEF 14A
Form DEF 14A - Other definitive proxy statements
PRE 14A
Form PRE 14A - Other preliminary proxy statements
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Ownerships
TYPE
HEADLINE
FILED AT
S-3
Form S-3 - Registration statement under Securities Act of 1933
SCHEDULE 13G/A
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
